Canada markets closed

BeiGene, Ltd. (BGNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
191.32-0.26 (-0.14%)
At close: 04:00PM EDT
191.32 0.00 (0.00%)
After hours: 04:01PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close191.58
Open192.81
Bid191.03 x 100
Ask191.46 x 100
Day's Range188.51 - 193.04
52 Week Range126.97 - 213.83
Volume135,311
Avg. Volume269,400
Market Cap21.018B
Beta (5Y Monthly)0.61
PE Ratio (TTM)N/A
EPS (TTM)-4.94
Earnings DateNov 07, 2024 - Nov 14, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est273.43
  • Zacks

    Wall Street Analysts See a 27.84% Upside in BeiGene (BGNE): Can the Stock Really Move This High?

    The consensus price target hints at a 27.8% upside potential for BeiGene (BGNE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

  • Simply Wall St.

    3 US Stocks That Could Be Trading At A Discount

    As the major U.S. stock indexes edged higher recently, investors are keeping a close eye on significant earnings reports and economic indicators that could influence market sentiment. Amid this cautious optimism, identifying undervalued stocks can be crucial for those looking to capitalize on potential discounts in the current market landscape.

  • Business Wire

    BeiGene to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

    SAN MATEO, Calif., August 28, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024, with a fireside chat at 10 a.m. EDT.